tirzepatide discontinuation Comparison of versus placebo for safety outcomes: (1) Meta-analysis results for tirzepatide of

Join a trusted program before capacity is reached and lock in results that are already changing lives

It's unique to retatrutide because no other approved obesity medication activates glucagon receptors

Sobos approach to weight loss is built around the full patient, not only the number on the scale

It activates both GIP and GLP-1 receptors, which together regulate appetite, metabolism, and blood sugar more effectively than medications that focus on a single hormone

Adding niacinamide to the formulation creates a more stable environment that extends shelf life and reduces the risk of degradation before the medication reaches you